291 related articles for article (PubMed ID: 15000301)
21. Large ascorbic acid intake.
Poser E
N Engl J Med; 1972 Aug; 287(8):412-3. PubMed ID: 5043534
[No Abstract] [Full Text] [Related]
22. [Can the administration of large doses of vitamin C have a harmful effect?].
Wróblewski K
Pol Merkur Lekarski; 2005 Oct; 19(112):600-3. PubMed ID: 16379336
[TBL] [Abstract][Full Text] [Related]
23. More evidence regarding vitamin C and kidney stone risk.
Mayo Clin Health Lett; 2013 May; 31(5):4. PubMed ID: 24701646
[No Abstract] [Full Text] [Related]
24. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
Glémain P; Prunet D
Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
[TBL] [Abstract][Full Text] [Related]
25. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
26. Acute oxalate nephropathy after a massive intravenous dose of vitamin C.
Wong K; Thomson C; Bailey RR; McDiarmid S; Gardner J
Aust N Z J Med; 1994 Aug; 24(4):410-1. PubMed ID: 7980244
[No Abstract] [Full Text] [Related]
27. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
[TBL] [Abstract][Full Text] [Related]
28. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation.
Dhar NB; Grundfest S; Jones JS; Streem SB
J Urol; 2005 Nov; 174(5):1844-6; discussion 1846. PubMed ID: 16217311
[TBL] [Abstract][Full Text] [Related]
29. High-dose supplementation with vitamin C--induced pediatric urolithiasis: the first case report in a child and literature review.
Chen X; Shen L; Gu X; Dai X; Zhang L; Xu Y; Zhou P
Urology; 2014 Oct; 84(4):922-4. PubMed ID: 25260453
[TBL] [Abstract][Full Text] [Related]
30. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
31. [Drug-induced calculi].
Hammann C; Guelpa G
Schweiz Rundsch Med Prax; 1993 Oct; 82(41):1129-32. PubMed ID: 8210886
[TBL] [Abstract][Full Text] [Related]
32. [Clinical strategies for prevention of drug-induced urinary calculi].
Kohjimoto Y; Sasaki Y; Hara I
Clin Calcium; 2011 Oct; 21(10):1457-63. PubMed ID: 21960230
[TBL] [Abstract][Full Text] [Related]
33. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
34. Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?
Laube N; Hergarten S
J Urol; 2005 Jun; 173(6):2175-7. PubMed ID: 15879882
[TBL] [Abstract][Full Text] [Related]
35. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
36. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
[TBL] [Abstract][Full Text] [Related]
37. Bariatric surgery, vitamin C, and kidney stones.
Weiss D
Cleve Clin J Med; 2010 Dec; 77(12):844; author reply 844. PubMed ID: 21186694
[No Abstract] [Full Text] [Related]
38. Risk of oxalate stones from large doses of vitamin C.
Herbert V
N Engl J Med; 1978 Apr; 298(15):856. PubMed ID: 634328
[No Abstract] [Full Text] [Related]
39. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
[TBL] [Abstract][Full Text] [Related]
40. Safety considerations with high ascorbic acid dosage.
Barness LA
Ann N Y Acad Sci; 1975 Sep; 258():523-8. PubMed ID: 946
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
